30
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
June 15, 2024
5819793
551854
1

9 nov 2020 año - The FDA grants an EUA for Eli Lilly’s monoclonal antibody treatment, bamlanivimab. Lilly showed that hospitalizations in COVID-19 patients decreased within 28 days, indicating that it prevents severe forms of the disease when administered quickly.

Añadido al timeline:

fecha:

9 nov 2020 año
Ahora mismo
~ 3 years and 6 months ago